Study title: Efficacy and safety of Symbioflor 1 in children and adolescents with chronic recurrent sinusitis (non-interventional trial)
| Type of medicine: Non-centrally authorised vaccines | |||||
| Therapeutic area: Bacterial Infections and Mycoses [C01] | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: Bacterial culture with MGE-score of at least 6 consisting of 1.5–4.5 x 107 cells capable and not capable of reproduction and cell debris of Enterococcus faecalis (DSM 16440) | |||||
| ATC code: L03AB01 | |||||
| Document link: | |||||
| Document date: 2011-09-28 | |||||
| Study number: 1193991649 | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | Y | |